Ronald N. Jones - Concepedia

Author

Ronald N. Jones

University of Iowa

Also Known As

Ronald N. Jones, Ronald N. Jones

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Iowa Indiana University – Purdue University Indianapolis Associação Paulista de Medicina University Medical Center St. Francis Regional Medical Center

About

Ronald N. Jones is an author at University of Iowa specializing in medicine, antimicrobial resistance, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	26	849
2	Health Sciences	11	12	409
3	Natural Sciences	2	2	45
4	Biochemistry	2	2	33
5	Cell Biology	1	1	33

Ronald N. Jones

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Nosocomial Bloodstream Infections Caused by Acinetobacter Species in United States Hospitals: Clinical Features, Molecular Epidemiology, and Antimicrobial Susceptibility Hilmar Wisplinghoff, Michael B. Edmond, Michael A. Pfaller, Clinical Infectious Diseases	2000	236
Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit Hélio S. Sader, Antônio Carlos Campos Pignatari, Ivani Lúcia Leme, Diagnostic Microbiology and Infectious Disease Antimicrobial SusceptibilityIntensive Care UnitHealth SciencesHealthcare-associated InfectionHospital Epidemiology	1993	198
Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) Ronald N. Jones, Matthew A.T. Croco, Kari C. Kugler, Diagnostic Microbiology and Infectious Disease AntibioticsSuspected PneumoniaRespiratory DiseasesMedicineHealthcare-associated Infection	2000	62
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents Arthur L. Barry, Ronald N. Jones Journal of Antimicrobial Chemotherapy Medicinal ChemistryAntimicrobial SusceptibilityHydrochloride SaltPharmacologyTosylate Salt	1989	62
Cefquinome (HR 111V) in vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals Stephen P. Murphy, Meridith E. Erwin, Ronald N. Jones Diagnostic Microbiology and Infectious Disease Equine-assisted TherapyMedicinePathogenesisVeterinary PathologyVeterinary Science	1994	49
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: Analysis of the correlations between in vitro test results and clinical response Ronald N. Jones, Michael N. Dudley Diagnostic Microbiology and Infectious Disease Clinical ResponsePharmacodynamic PrincipalsAntibioticsHealth SciencesMedicine	1997	42
Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830) Ronald N. Jones, Arthur L. Barry Diagnostic Microbiology and Infectious Disease Medicinal ChemistryYtr 830Vitro TestingPharmacologyPharmacotherapy	1989	38
In vitro activity of three carbapenem antibiotics comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide Daryl J. Hoban, Ronald N. Jones, Nobuhisa Yamane, Diagnostic Microbiology and Infectious Disease AntibioticsAntibacterial AgentAerobic PathogensMicrobiologyAntimicrobial Chemotherapy	1993	35
In vitro evaluation of ramoplanin (A16686 or MDL62198): A new depsipeptide complex for potential topical use Ronald N. Jones, Arthur L. Barry Diagnostic Microbiology and Infectious Disease MedicineTopical DrugNew Depsipeptide ComplexSkin PharmacologyDermatology	1989	34
In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393) Beth M. Briggs, Ronald N. Jones, Meridith E. Erwin, Diagnostic Microbiology and Infectious Disease Medicinal ChemistryPharmaceutical ScienceMedicineNatural SciencesVitro Activity Evaluations	1991	33

Page 1